Related Experiment Videos
[Leucine-sensitive hypoglycaemia and its treatment with diazoxide (author's transl)]
Insights
A seven-month-old infant with leucine-sensitive hypoglycemia experienced seizures. A leucine-restricted diet failed, but diazoxide treatment resolved hypoglycemia and seizures, with normal development anticipated.
Area of Science:
- Pediatric Endocrinology
- Metabolic Disorders
- Neurology
Background:
- Leucine-sensitive hypoglycemia is a rare metabolic disorder.
- Infantile convulsions can stem from various underlying causes, including metabolic imbalances.
Observation:
- A seven-month-old infant presented with recurrent convulsions attributed to leucine-sensitive hypoglycemia.
- Initial management with a leucine-deficient diet proved ineffective in controlling the seizures.
Findings:
- The administration of diazoxide, a potassium channel opener, successfully halted the convulsions.
- Diazoxide treatment normalized blood glucose levels, resolving the hypoglycaemia.
- The infant's neurological development is expected to be within normal parameters following treatment.
Implications:
- Diazoxide represents a potential therapeutic option for refractory leucine-sensitive hypoglycemia.
- Early diagnosis and effective management are crucial for preventing neurological sequelae in infants with metabolic disorders.
- This case highlights the importance of considering pharmacological interventions when dietary management alone is insufficient.
Abstract:
A seven months old infant suffered from convulsions due to leucine-sensitive hypoglycaemia. The convulsions could not be stopped by a diet lacking in leucine, but ceased after additional application of diazoxide; hypoglycaemia was no longer observed the mental development of the child is hoped to be normal.